- Summary
- Table Of Content
- Methodology
Traumatic Brain Injury Treatment Market Size :
Consegic Business Intelligence analyzes that the traumatic brain injury market size is growing with a CAGR of 6.7% during the forecast period (2024-2031). The market accounted for USD 3,461.33 million in 2023 and is projected to be valued at USD 5,437.23 Million by 2031.
Traumatic Brain Injury Treatment Market Scope & Overview :
Traumatic brain injury (TBI) is defined as a sudden injury, which causes damage to the brain. Such injury may occur due to a blow, bump, or jolt to the head. This is a closed head injury. A traumatic brain surgery also happens due to penetration of an object into the skull. Symptoms of a trauma brain injury are mild, moderate, and severe. Likewise, concussion is one of the profound symptoms of traumatic brain injuries. As per the analysis, the effects of a concussion are serious, but most people completely recover within time. However, more severe traumatic brain injuries lead to serious physical and psychological symptoms, coma, and even death.
Moreover, men are more likely to get a traumatic brain injury than women. They are also more likely to have serious TBI due to their vast exposure to unfortunate accidents. In addition to this, adults aged 65 and older are also at the greatest risk for being hospitalized and dying from a traumatic brain injury. Similarly, the treatments for traumatic brain injury depend on many factors, which includes the size, severity, and location of the brain injury.
Traumatic Brain Injury Treatment Market Insights :
Traumatic Brain Injury Treatment Market Dynamics - (DRO) :
Key Drivers :
Increasing prevalence of road traffic injuries is particularly contributing to remarkable market expansion
Irresponsible driving plays a pivotal role in contributing to rising incidences of traumatic brain injuries across the globe. The phenomenal number of vehicle collisions is another vital factor responsible for increasing the number of individuals having traumatic brain injuries and increasing solid demand for effective treatments for proper cures. Similarly, as per the analysis, the large amount of drunk and driving cases is another significant factor expanding the use of treatments for a robustly surging number of traumatic brain injuries. In addition to this, low safety precautions and breaking of traffic guidelines are other impactful factors driving the traumatic brain injury treatment market growth.
Furthermore, the growing prevalence of injuries on roads leads to more incidences of traumatic brain injuries across the world. For instance, according to the data published by the World Health Organization (WHO) in December 2023, approximately 1.19 million lives of people are cut short due to a devastating road traffic crash accident every year, with between 20 and 50 million people suffering from non-fatal injuries, with many incurring a disability. Therefore, contributes to exceptional demand for effective treatments for traumatic brain injuries in the market.
Rising prevalence of traumatic brain injuries among defence and military personnel is promoting the market expansion
Personnel belonging to defence and military service are more prone to face difficult and dangerous incidences, which result in fatal injuries. As a result, many defence professionals also get affected by traumatic brain injuries, further encouraging them to take appropriate treatment methods to recover. As per the analysis, a large number of attacks, blasts, fights, and drills are some of the major factors contributing to a cumulative increase in traumatic brain injuries in military and defence personnel. In addition to this, the large occurrence of prolonged and serious traumatic brain injuries in military and defence professionals is another dependable factor causing the boom in traumatic brain injury treatment market trends.
Moreover, the vast presence of traumatic brain injuries in service members across the world is augmenting the demand for advanced treatments for traumatic brain injuries in the market. For instance, according to the data published by the U.S. Department of Veterans Affairs in January 2021, nearly 414,000 traumatic brain injuries occurred in U.S. service members across the globe between duration of 2000 and late 2019, with more than 185,000 veterans who used Veteran Affairs getting diagnosed with at least one TBI. Therefore, the above-mentioned factors are rigorously boosting the phenomenal market growth.
Key Restraints :
The individual variability of each patient with traumatic brain injury is posing a significant threat to the substantial market growth.
Individual variabilities play a pivotal role in complicating development and delivery of effective treatments for traumatic brain injuries. The broad range of responses and individual trajectories in people with TBI with the same injuries is contributing to more complexity in the market. In addition to this, variability in symptoms ranging from mild to severe, recovery speed of each individual, and different psychological factors are other contributing factors in the slow traumatic brain injury treatment market growth. Likewise, as per the analysis, the different genetic makeup and immunity of everyone are other impacting factors thwarting the stable market trends.
Furthermore, the rising effect of heterogeneity on research studies conducted to find out novel approaches are presenting a significant threat in the market. For instance, according to the article published by the American Speech-Language-Hearing Association (ASHA) in April 2021, heterogeneity in the patient population is frequently referred as a restraint and is often understood as a factor plummeting certainty in the generalizability of research findings and as a source of contradictory findings across studies. Hence, the afore-mentioned factors are impeding the intensity of the traumatic brain injury treatment market growth.
Future Opportunities :
Widening research and development activities are anticipated to propel the market expansion over the forecast duration
The wide range of research and development activities conducted by key players, organizations, and educational institutions contribute to advancement in new techniques creating lucrative traumatic brain injury treatment market opportunities and trends in the coming years. As per the analysis, this results in innovations of new treatment approaches and drives the market in an upward manner. The new technological advancements such as the implantation of devices are certainly creating new opportunities in the market. In addition to this, customized changes offered to each patient in research studies are another peculiar factor projected to direct the proficient market expansion.
Furthermore, the new findings and innovations obtained through rigorous research studies are expected to drive the market in the forthcoming years. For instance, according to the data published by the Stanford Medicine, an educational institute in December 2023, a new technique using deep brain stimulation personalized to each patient surpassed the expectations of researchers in treating the cognitive damages from moderate to severe traumatic brain injuries. Thus, contributing to significant expansion in the traumatic brain injury treatment market trends and opportunities over the forecast period.
Traumatic Brain Injury Treatment Market Report Insights :
| Report Attributes | Report Details |
| Study Timeline | 2018-2031 |
| Market Size in 2031 | USD 5,437.23 Million |
| CAGR (2024-2031) | 6.7% |
| By Treatment | Medications (Anti-seizure Drugs, Coma-inducing Drugs, and Others), Surgeries, Rehabilitation Therapies, and Others |
| By End-user | Hospitals, Clinics, Rehabilitation Centres, and Others |
| By Route of Administration | Oral, Parenteral, and Others |
| By Region | North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
| Key Players | Merck KGaA, Bayer Group, Pfizer Inc., Johnson & Johnson Limited, Chemicea Limited, SimSon Pharma Limited, MB Sugars and Pharmaceuticals Pvt. Ltd., Intas Pharmaceuticals Ltd., Eurocrit Labs International, Actiza Pharmaceutical Private Limited, Spectrum Chemical, and Healing Pharma India Pvt. Ltd |
| Geographies Covered | |
| North America | U.S. Canada Mexico |
| Europe | U.K. Germany France Spain Italy Russia Benelux Rest of Europe |
| APAC | China South Korea Japan India Australia ASEAN Rest of Asia-Pacific |
| Middle East and Africa | GCC Turkey South Africa Rest of MEA |
| LATAM | Brazil Argentina Chile Rest of LATAM |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Restraint or Challenges, Opportunities, Environment & Regulatory Landscape, PESTLE Analysis, PORTER Analysis, Key Technology Landscape, Value Chain Analysis, Cost Analysis, and Regional Trends & Forecast |
Traumatic Brain Injury Treatment Market Segmental Analysis :
By Treatment :
The treatment segment is categorized into medications, surgeries, rehabilitation therapies, and others. In 2023, the medications segment accounted for the highest market share in the traumatic brain injury treatment market. Medications are the most common treatment method used for idiopathic pulmonary fibrosis and it is further bifurcated into anti-seizure drugs and coma-inducing drugs. The convenient route of administration offered by medications is one of the biggest reason healthcare professionals recommend this treatment type. As per the analysis, in addition to this, use of antidepressants is another reliable factor directing the segment. For instance, according to the neuropsychological review published by the National Library of Medicine in June 2023, antidepressants such as citalopram, sertraline, and methylphenidate are effective in reducing depressive symptoms in patients with traumatic brain injury treatment.
Moreover, rehabilitation therapies is expected to grow at the fastest CAGR over the forecast period. The expansion of this segment is attributed to the increasing importance of rehabilitation therapies as a post-surgical treatment in the market. In addition to this, the widening horizon of preference of patients is another major factor expected to boost the segment trends in the upcoming years.
By Route of Administration :
The route of administration segment is categorized into oral, parenteral, and others. In 2023, the oral segment accounted for the highest traumatic brain injury treatment market share in the traumatic brain injury treatment market and is also expected to grow at fastest CAGR over the forecast period. The oral route of administration is the most common and convenient method of taking medications. The excellent effectiveness offered by this route of administration type is one of the favorable factors influencing the prosperous segmental expansion in the market.
Moreover, as per the analysis, the expansion of advances in oral route of administration is another versatile factor boosting the segment relentlessly. For instance, according to the article published by the National Library of Medicine (NLM) in February 2023, advantages of oral delivery system such as non-invasiveness, patient compliance, convenience of drug administration, drug solubility, mucosal permeability, and stability in the gastrointestinal tract environment boost its popularity in the treatment solutions. Thus, the afore-mentioned factors will further add to exceptional segment expansion in the traumatic brain injury treatment market trends.
By End User :
The end-user segment is categorized into hospitals, clinics, rehabilitation centres, and others. In 2023, the hospitals segment accounted for the highest market share of 41.03% in the traumatic brain injury treatment market. Hospitals are the most common end-user in the segment owing to the solid potential of hospitals to provide surgeries, medications, therapies, consultations, medical care, diagnosis, and other procedures to facilitate the smooth flow of treatment. Moreover, as per the analysis, the wide availability of hospitals across the globe is another remarkable factor expected to fuel the segment over the upcoming years by conducting more diagnostic procedures. For instance, according to the data published by the Institute for Government in October 2023, British hospitals conducted a total of 24.4 million diagnostic tests in the year 2023-23, which is 5% more than the year 2019-20. Therefore, propelling the segment in the traumatic brain injury treatment market.
Furthermore, the rehabilitation centres segment is expected to grow at the fastest CAGR over the forecast period. The solid expansion of this segment is driven by the increased popularity of rehabilitation therapies among patients affected by traumatic brain injuries. In addition to this, the effectiveness of rehabilitation techniques in reducing psychological trauma is also expected to conduct market trends in the coming years.
By Region :
The regional segment includes North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America.
In 2023, Asia Pacific accounted for the highest market share of 34.31% valued at USD 1,187.58 Million in 2023 and is expected to reach USD 1,959.03 Million in 2031 and is expected to grow at a CAGR of 7.7%. In the Asian Pacific region, China accounted for the highest market share of 25.11% in 2023. The expansion of this region is majorly attributed to increased traumatic brain injury treatment market demand in Asian Pacific countries, owing to an increased rate of road traffic accidents. Based on the traumatic brain injury treatment market analysis, the phenomenal prevalence of low and middle-income nations in the Asia Pacific is another notable factor stimulating market expansion. For instance, according to the data stated by the World Health Organization (WHO) in December 2023, 92% of the fatalities on the roads across the world occur in low- and middle-income countries, even though these countries have around 60% of the world's vehicles. Additionally, more than 90% of road traffic deaths occur in low and middle-income countries. Thus, the presence of a large number of low and middle-income countries in Asia Pacific is contributing to increased incidences of traumatic brain injuries and further propelling the exceptional demand and trends in the Asia Pacific region.
The growth of this region is majorly attributed to the increasing demand for effective surgeries and recoveries from traumatic brain injuries. Likewise, the rising population and developing transport routes are other prominent factors expected to fuel the robust growth of the traumatic brain injury treatment market in upcoming years.
Top Key Players & Market Share Insights :
The global traumatic brain injury treatment market is highly competitive, with several large players and numerous small and medium-sized enterprises. These companies have strong research and development capabilities and a strong presence in the market through their extensive product portfolios and distribution networks. The market is characterized by intense competition, with companies focusing on expanding their product offerings and increasing their market share through mergers, acquisitions, and partnerships. The key players in the global traumatic brain injury treatment industry include-
The key players in the market include-
- Merck KGaA
- Bayer Group
- Pfizer Inc.
- SimSon Pharma Limited
- MB Sugars and Pharmaceuticals Pvt. Ltd.
- Healing Pharma India Pvt. Ltd
- Chembond Chemicals Limited
- Johnson & Johnson Limited
- Chemicea Limited
- Intas Pharmaceuticals Ltd.
- Eurocrit Labs International
- Actiza Pharmaceutical Private Limited
- Spectrum Chemical
Recent Industry Developments :
- In October 2023, Pharmaceuticals firm Hetero acquired the manufacturing plant of Johnson & Johnson at Penjerla in Telangana and will invest an additional Rs 600 crore on its upgradation.
Key Questions Answered in the Report
What was the market size of the traumatic brain injury treatment market in 2023? +
In 2023, the market size of traumatic brain injury treatment was USD 3,461.33 million.
What will be the potential market valuation for the traumatic brain injury treatment market by 2031? +
In 2031, the market size of traumatic brain injury treatment is expected to reach USD 5,437.23 million.
What are the key factors driving the growth of the traumatic brain injury treatment market? +
Increasing prevalence of road traffic injuries is particularly contributing to remarkable market growth. Rising prevalence of traumatic brain injuries among defense and military personnels is promoting market growth.
What is the dominating segment in the traumatic brain injury treatment market by route of administration? +
In 2023, the oral segment accounted for the highest market share in the overall traumatic brain injury treatment market.
Based on current market trends and future predictions, which geographical region will have the fastest impact on the traumatic brain injury treatment market's growth in the coming years? +
Asia Pacific is expected to be the fastest-growing region in the market during the forecast period.
